Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
FDF
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 869113-09-7
2. Incruse Ellipta
3. Gsk573719a
4. Umeclidinium (bromide)
5. Anoro Ellipta
6. 1-[2-(benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-quinuclidinium Bromide
7. Gsk-573719a
8. 7an603v4jv
9. Mfcd27976798
10. 1-(2-(benzyloxy)ethyl)-4-(hydroxydiphenylmethyl)quinuclidin-1-ium Bromide
11. Diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol Bromide
12. Chembl523299
13. Diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol;bromide
14. Unii-7an603v4jv
15. Umeclidinium Bromide [usan]
16. Umeclidinium Brom
17. Umeclidinium Bromide [usan:inn]
18. Umeclidinii Bromidum
19. 4-[hydroxy(diphenyl)methyl]-1-[2-[(phenylmethyl)oxy]ethyl]-1-azoniabicyclo[2.2.2]octane Bromide
20. 4-[hydroxy(diphenyl)methyl]-1-{2-[(phenylmethyl)oxy]ethyl}-1-azoniabicyclo[2.2.2]octane Bromide
21. Umec
22. Bromure D'umeclidinium
23. Bromuro De Umeclidinio
24. Incruse Ellipta (tn)
25. Schembl109931
26. Chebi:79040
27. Dtxsid50235966
28. Umeclidinium Bromide [mi]
29. Umeclidinium Bromide (jan/usan)
30. Hms3885a04
31. Umeclidinium Bromide [inn]
32. Umeclidinium Bromide [jan]
33. Bcp11148
34. Ex-a1683
35. Umeclidinium Bromide [vandf]
36. Umeclidinium Bromide [who-dd]
37. Akos025404842
38. Ccg-269761
39. Cs-0874
40. Sb16738
41. Ac-30852
42. As-57320
43. Hy-12100
44. Sy226333
45. Umeclidinium Bromide [orange Book]
46. Ft-0775078
47. D10181
48. A916880
49. Q15624035
50. Trelegy Ellipta Component Umeclidinium Bromide
51. Umeclidinium Bromide Component Of Trelegy Ellipta
52. 1-[2-(benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-quinuclidiniumbromide
53. 1-(2-(benzyloxy)ethyl)-4-(hydroxydiphenylmethyl)-1-azoniabicyclo(2.2.2)octane Bromide
54. 1-[2-(benzyloxy)ethyl]-4(hydroxydiphenylmethyl)-1-azoniabicyclo[2.2.2]octane Bromide
55. 1-[2-(benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-azabicyclo[2.2.2]octan-1-ium Bromide
56. 1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane Bromide
57. 1-(2-((benzyl)oxy)ethyl)4-(hydroxydi(phenyl)methyl)-1-azabicyclo(2.2.2)octan-1-ium Bromide
58. 1-azoniabicyclo(2.2.2)octane, 4-(hydroxydiphenylmethyl)-1-(2-(phenylmethoxy)ethyl)-, Bromide (1:1)
59. Gsk-573719 Pound>> Gsk573719 Pound>> Gsk 573719 Pound>>gsk573719a;gsk-573719a;gsk 573719a
Molecular Weight | 508.5 g/mol |
---|---|
Molecular Formula | C29H34BrNO2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 8 |
Exact Mass | 507.17729 g/mol |
Monoisotopic Mass | 507.17729 g/mol |
Topological Polar Surface Area | 29.5 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 543 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Incruse ellipta |
PubMed Health | Umeclidinium (By breathing) |
Drug Classes | Respiratory Agent |
Active Ingredient | Umeclidinium bromide |
Dosage Form | Powder |
Route | Inhalation |
Strength | eq 62.5mcg base/inh |
Market Status | Prescription |
Company | Glaxo Grp England |
2 of 2 | |
---|---|
Drug Name | Incruse ellipta |
PubMed Health | Umeclidinium (By breathing) |
Drug Classes | Respiratory Agent |
Active Ingredient | Umeclidinium bromide |
Dosage Form | Powder |
Route | Inhalation |
Strength | eq 62.5mcg base/inh |
Market Status | Prescription |
Company | Glaxo Grp England |
Rolufta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
R03BB07
R03BB07
R03BB07
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03B - Other drugs for obstructive airway diseases, inhalants
R03BB - Anticholinergics
R03BB07 - Umeclidinium bromide
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Umeclidinium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Umeclidinium Bromide, including repackagers and relabelers. The FDA regulates Umeclidinium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Umeclidinium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Umeclidinium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Umeclidinium Bromide supplier is an individual or a company that provides Umeclidinium Bromide active pharmaceutical ingredient (API) or Umeclidinium Bromide finished formulations upon request. The Umeclidinium Bromide suppliers may include Umeclidinium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Umeclidinium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Umeclidinium Bromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Umeclidinium Bromide active pharmaceutical ingredient (API) in detail. Different forms of Umeclidinium Bromide DMFs exist exist since differing nations have different regulations, such as Umeclidinium Bromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Umeclidinium Bromide DMF submitted to regulatory agencies in the US is known as a USDMF. Umeclidinium Bromide USDMF includes data on Umeclidinium Bromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Umeclidinium Bromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Umeclidinium Bromide suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Umeclidinium Bromide Drug Master File in Korea (Umeclidinium Bromide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Umeclidinium Bromide. The MFDS reviews the Umeclidinium Bromide KDMF as part of the drug registration process and uses the information provided in the Umeclidinium Bromide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Umeclidinium Bromide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Umeclidinium Bromide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Umeclidinium Bromide suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Umeclidinium Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Umeclidinium Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Umeclidinium Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Umeclidinium Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Umeclidinium Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Umeclidinium Bromide suppliers with NDC on PharmaCompass.
Umeclidinium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Umeclidinium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Umeclidinium Bromide GMP manufacturer or Umeclidinium Bromide GMP API supplier for your needs.
A Umeclidinium Bromide CoA (Certificate of Analysis) is a formal document that attests to Umeclidinium Bromide's compliance with Umeclidinium Bromide specifications and serves as a tool for batch-level quality control.
Umeclidinium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Umeclidinium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Umeclidinium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Umeclidinium Bromide EP), Umeclidinium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Umeclidinium Bromide USP).
LOOKING FOR A SUPPLIER?